Funding-DEVELOPMENT OF INTERVENTIONAL AGENTS FOR
INFECTIOUS DISEASES; March 1,
2011
Agency
Department of Health
and Human Services
Description
The National Institute
of Allergy and Infectious Diseases NIAID, Division of
Microbiology and Infectious Diseases (DMID) has a requirement for a
contractor to provide a suite of product development services. While
the overall suite of services is comprehensive, the intent is to
provide individual services on a case-by-case basis for a diverse
collection of product candidates, rather than carry a single product
candidate through an entire preclinical development pathway.
The development and introduction of new therapeutics against potential agents of
bioterrorism, drug-resistant pathogens, emerging and re-emerging
infectious diseases, as well as infectious diseases prevalent in
resource-limited countries, remain a high public health priority. To
assist in filling these public health gaps, the NIAID requires a
nontraditional, proactive, and product development-oriented program to
provide preclinical development support for promising therapeutic
candidates that emerge from academia, the private sector, or other
sources. The suite of services will encompass those activities commonly
associated with the development of interventional products for
infectious disease required for New Drug Application (NDA), Biologic
License Applications (BLA) and/or Investigational New Drug (IND)
applications. Consequently, the DMID recognizes that to obtain the full
spectrum of expertise or facilities required to perform all activities
set forth in this solicitation, individual organizations will likely
need the expertise and resources of other organizations or persons
through consortia agreements, partnerships, subcontracts, and/or
consultants.
The services shall be
directed at the following: 1) diseases caused by pathogens and toxins
on the National Institute of Allergy and Infectious Diseases (NIAID)
Category A, B, and C Priority Pathogens list; 2) emerging and re
emerging infectious diseases; 3) antimicrobial resistant and multi drug
resistant infections; 4) other bacterial infections; 5) fungal
infections; 6) viral infections; and 7)parasitic diseases. The
Contractor shall be required to carry out the Scope and Activities
defined in the following five Task Areas: (1) Administrative,
Management and Technical Support: One Task Order will be assigned under
this Task Area. The Task Order will be a cost-reimbursement, term
(level of effort) type contract with a Base Period of 12 months and
multiple Options to extend the Base Period of Performance in 12-month
increments up to a total of 10 years to continue the same requirement.
Technical Requirements will be defined in the individual Task
Orders. NIAID anticipates award a single-award Indefinite Delivery
Indefinite Quantity (IDIQ) contract to one organization that meets the
overall qualifications needed to fulfill the technical requirements of
the solicitation, providing a guaranteed minimum award. Task orders for
specific tasks requiring specialized expertise will be issued after the
award of the IDIQ contract for an ordering period of seven years
beginning on or about September 30, 2011. Any responsible offeror may
submit a proposal which will be
considered by the Agency. This RFP will
be available
electronically on/about December 1, 2010, and may be
accessed through FedBizOpps http://www.fbo.gov/.
Announcement
Number:
NIAID-DMID-NIHAI2010090
Closing
Date: Mar 01, 2011 3:00
pm Eastern
Link to Full
Announcement
Contact
Information
Edward Shane
Ryan,
Phone:
301-451-3692
Fax:
301-402-0972
Michael
Finn,
Contract
Specialist
Phone:
301-496-3699
Fax:
301-402-0972